Thursday 25 August 2011

Ventilation tubes how to delay their extrution?

Introduction:

Ventilation tubes are inserted to cure recurrent / frequent bouts of acute otitis media / chronic otitis media with effusion. Grommet insertion is particularly useful to treat patients with chronic mucoid otitis media.

Delay in insertion of ventilation tubes in these patients can cause chronic otitis media / chronic mastoiditis in these patients. Ventilation tubes measuring about 1.1 mm are known to last for atleast a year before being extruded. In patients with prolonged eustachean tube dysfunction these tubes help in prevention of atelectasis. If tubes measuring 1.5 mm are used they could stay in situ for prolonged duration thereby allowing adequate time for the middle ear healing process.

Studies have demonstrated that proper placement of these ventilation tubes can be helpful in delaying the process of extrusion.

Ventilation tubes should not be inserted in the postero superior quadrant because of the impending risk of incus dislocation. Similary placement in the postero inferior quadrant is also discouraged because of the risk of damage to round window. In this location there is also the added risk of damaging a high jugular bulb which could be an anatomical variant.

Classically the antero inferior quadrant is perferred because of the proximity to eustachean tube. Insertion in this area has one important flip side, i.e. Early extrusion of the ventilation tube.


Insertion of ventilation tune i.e. In the antero superior quadrant adjacent ot the handle of malleus and half way between the umbo and short process of malleus will serve the purpose of ventilation of middle ear adequately. Ventilation tubes placed in this quadrant have been known to stay in place for more than a year serving the important ventilatory function of middle ear cavity.

Sunday 21 August 2011

Anatomy of anterior ethmoidal artery

Introduction:

Anatomical knowledge of anterior ethmoidal artery is vital during endoscopic sinus procedures if complications are to be minimized. During its course the anterior ethmoidal artery crosses three cavities (the orbit, ethmoidal labyrinth and anterior cranial fossa of skull). The anterior ethmoidal artery enters the olfactory fossa through the lateral lamella of cribriform plate along the anterior ethmoidal sulcus. The bone over the anterior ethmoidal sulus is very thin and is at risk during endoscopic surgery. The relationship of the anterior ethmoidal artery to the roof of the ethmoid is highly variable and is at risk during endoscopic sinus surgeries. Identification of this artery is important in identifying frontal sinus outflow tract and superior limits of skull base.


Areas supplied by anterior ethmoidal artery:

It supplies the anteror ethmoidal cells and the frontal sinus. As it courses along the olfactory fossa it gives rise to meningeal vessels. This artery also supplies the anterior third of nasal septum and lateral nasal wall.

Stamberger reported that anterior ethmoidal artery may be in direct contact with skull base. This is particularly true if the roof of the ethmoid sinus is low. In majority of cases he reported that a bony mesentry could connect the anterior ethmoidal artery to the skull base. He also reported that there could be a space of about 5 mm between the anterior ethmoidal artery and skull base.

According to Gotwal who extensively studied the course of anterior ethmoidal artery by viewing coronal CT scans of nose and sinuses found that the presence of a notch in the medial wall of orbit indicates the probable site of antrior ethmoidal foramen. He also suggested that the presence of focal funneling in the olfactory fossa could indicate the probable position of anterior ethmoidal artery.


Coronal CT showing a dimple in the medial wall of orbit indicating the probable position of anterior ethmoidal artery canal.


Coronal CT showing anterior ethmoidal artery coursing close to skull base


Coronal CT paranasal sinuses showing the probable location of anterior ethmoidal artery close to the roof of frontal sinus and skull base.


Coronal CT showing anterior ethmoidal canal during its course through the anterior ethmoidal cells

Saturday 20 August 2011

What is angioneurotic oedema? Classify it on pathological basis and outline the management of a case with angioneurotic oedema.

Introduction:



Angioneurotic oedema is associated with rapid swelling of dermis, subcutaneous tissue, mucosa and submucosal tissues. It should be differentiated from urticaria where oedema occurs in the upper dermis. The term angioneurotic oedema is a misnomer which was used with the belief that nervous system was involved in some way as a causative factor. It was first introduced by Quinke in 1882. It was in 1888 Osler came out with a complete description of hereditary angioneurotic oedema.

The progression of angioneurotic edema could be very rapid and could even be life threatening. Major danger is airway compromise.



Classification:



Angioneurotic oedema can be classified into



Hereditary



Acquired.



Acquired angioneurotic oedema:

This is commonly caused by allergy and is usually associated with allergic symptoms like urticaria. It can also occur as a side effect to certain drugs (ACE inhibitors).



Hereditary angioneurotic oedema:

As the name suggests it is hereditary and is inherited as autosomal dominant form. This type is known to exist in three forms distinguished according to the underlying gene involvement. The first and the second forms as caused by abnormalities / mutations of SERPING1 gene. These mutations can cause decrease in the circulating levels of C1-inhibitor protein (type I hereditary anginoneurotic oedema) or dysfunctional forms of the same protein (this is type II hereditary angioneurotic oedema). Type III hereditary angioneurotic oedema is associated with mutations of F12 gene. This gene is supposed to encode the coagulation factor 12. Almost all these forms of hereditary angioneurotic odema cause abnormal activation of complement system and cause swelling / oedema in other regions of the body like digestive tract. If this swelling involves larynx it can compromise the airway.



Signs / symptoms:



The following areas may become swollen within minutes to hours:



Skin of the face and around the mouth

Mucosa of mouth and throat

Tongue

Hands

Decreased sensation due to compression of nerves

Airway compromise / stridor

In acquired angioneurotic oedema exposure history of allergen can be elicited



In hereditary angioneurotic oedema there is not obvious cause. It could be as trivial as mild trauma / dental scaling etc. These patients do not exhibit urticaria / allergic rashes as it is not an allergic response. These patients may manifest with acute abdominal pain and watery diarrhoea. Acute abdominal pain is also associated with lymphocytosis. Swelling may also occur in the extremities.



Investigations:



Complete blood count

Renal function tests

Serum electrolyte estimation ( in cases of diarrhoea)

Mast cell tryptase levels may be raised in acquired angioneurotic oedema

Deficiency of C1 inhibitor

Depletion of complement factors 2 and 4 indicate deficiency of C1 inhibitor



Hereditary angioneurotic oedema can be identified when the patient fails to respond to antihistamines and steroids.



Pathophysiology:



Bradykinin plays a vital role in the pathogenesis of all forms of angioneurotic oedema. This peptide is a potent vasodilator which increases vascular permeability causing rapid accumuation of fluid in the interstitium. Reducing / blocking this peptide plays a vital role in alleviating the symptoms.

ACE inhibitors block ACE the enzyme that is responsible for deactivation of bradykinin. It should be borne in mind that bradykinin is produced by continuous activation of complement system. Complement system is continuosly activated by deficiency of C1 esterase which is a potent inhibitor of complement system. This is made possible due to continuous production of Kallikrein.



Differences between the three types of hereditary angioneurotic odemea:



Type I : Decreased levels of C1 inhibitor



Type II : Normal levels of C1 inhibitor but decreased function



Type III : There is no abnormality involving C1 inhibitor, and is an X linked dominant disorder mainly affecting females. This condition can be exacerbated by pregnancy / contraceptive pills and other hormone therapy.



Aggravating factors:



Consumption of food that causes vasodilatation (alcohol / cinnamon)

Use of Ibuprofen / aspirin may increase the probablity in some patients



Use of Bromelain in combination with turmeric has been proved to be beneficial in certain cases.



Management:



Allergic – In allergy induced angioneurotic oedema avoidance of allergen and use of antihistamines may prevent future attacks. Cetrizine is the commonly prescribed antihistamine in the management of allergic angioneurotic oedema. Severe allergic angioneurotic oedema may require desensitization if the putative allergen could be identified. Use of steroids have also found to be beneficial in these patients.









Drug induced angioneurotic oedema: Common drugs involved include ACE inhibitor. Avoidance of these drugs will help.



Hereditary angioneurotic oedema : Since C1 Inhibitor is deficient in these patients C1 inhibitor concentrates can be administered. In acute cases frozen plasma may be beneficial as it contains adequate amounts of C1 inhibitor.

Thursday 4 August 2011

Histological classification of fungal sinusitis

Four distinct histologic categories of fungal sinusisits have been recognised. This classification goes a long way in deciding the optimal management modality in patients suffering from this condition.

1. Allergic fungal sinusitis
2. Non invasive fungal colonization (fungal ball)
3. Chronic invasive fungal sinusitis
4. Acute fulminant fungal sinusitis

Acute fulminant fungal sinusitis is commonly seen in immunocompromised / diabetic patients. This can really be fatal and hence need to be treated aggressively with systemic antifungal agents.

Allergic fungal sinusitis does not require antifungal therapy but should be treated aggressively for the underlying allergy. Aim of treating these patients aggressively is to reduce the incidence of recurrence rates. After surgical removal of the disease these patients should be treated with corticosteroids with simultaneous montoring of serum IgE levels. This also reduces clinical symptoms. Current management modalities also include antileukotriene agents.

Allergic fungal sinusitis can be suspected if allergic mucin is present in the specimen. This mucin is a special type and could be green, brown or black in color. The material present has a consistency of that of clay and the cut surface appears laminated. Microscopically allergic mucin appears eosinophilic on H&E stain. There is also associated presence of charcot leyden crystals and eosinophils. The mucosal tissue demonstrated changes consistent with that of inflammatory polyposis.

Histological diagnosis of non invasive fungal sinusitis is really easy as fungal organims can be clearly seen in abundance under H&E.

Acute fulminant sinusitis is characterised by tissue invasion by fungal organism. In this type angioinvasion is really common in contrast chronic invasive fungal sinusitis is characterised by tissue invasion and formation of granulation tissue.

Currently one more entity has been added.

EMRS: (eosinophilic mucin rhinosinusitis)

This entity is characterised by the presence of allergic mucin but fungal hyphae is not evident. Fungal cultures too turn out to be negative.